Cutler Group LP Oramed Pharmaceuticals Inc. Put Options Transaction History

Cutler Group LP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	SELL	$4.6 - $9.91 $919 - $1,982	-200 Reduced 66.67%	100 $0
Q4 2021 Jan 18, 2022	BUY	$12.98 - $29.75 $1,298 - $2,975	100 Added 50.0%	300 $1,000
Q3 2021 Oct 26, 2021	BUY	$12.13 - $23.82 $2,426 - $4,764	200 New	200 $0

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $90.9M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.